Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› EGFR Mutation-Related Tumors
Clinical trial register · Taiwan

EGFR Mutation-Related Tumors Trials in Taiwan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Taiwan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2865 matching records held by the registry are in this view. Synced 19 Nov 2026, 03:18 UTC
2865
Studies in scope
all four open statuses
1570
Recruiting now
open to new participants
340
Lead sponsors
across recruiting studies
Top sites
Taipei City 1
Narrow the registerReset
Recruitment status
Phase
Site location
Taipei City1
All 1 locations
Target enrolment
to

EGFR Mutation-Related Tumors trials in Taiwan

1 of 2865 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Taiwan
Start
Active, closed
Nalo Therapeutics Inc.
Phase 1
258
Taipei City
2022-10-05
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Taiwanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 November 2026. https://priyalifescience.com/clinical-trials-taiwan/condition/egfr-mutation-related-tumors

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Taiwan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,865 studies in total at the last sync on 19 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies listing the condition EGFR Mutation-Related Tumors.

How many EGFR Mutation-Related Tumors trials are recruiting in Taiwan?

0 of the 1 studies on this page are recruiting new participants as of the 19 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (EGFR Mutation-Related Tumors), 1 studies
PhaseStudiesRecruitingShare
Phase 110100%

Most active sponsors

Lead sponsors with the most studies (EGFR Mutation-Related Tumors)
Lead sponsorStudiesRecruiting
Nalo Therapeutics Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.